蜜芽传媒

Thousands of women with previously untreatable breast cancer have been given a chance to take a new drug that could make a big impact on their lives.

The drug is called Palbociclib and its one of a class of drugs described by one expert as "the most important breakthrough for women with advanced breast cancer in the last two years."

Craig Eagle is head of oncology at Pfizer UK.

(Image: Pills, credit: 蜜芽传媒)